224 related articles for article (PubMed ID: 3875096)
21. Complex regulation of class II gene expression: analysis with class II mutant cell lines.
Glimcher LH; McKean DJ; Choi E; Seidman JG
J Immunol; 1985 Nov; 135(5):3542-50. PubMed ID: 2995495
[TBL] [Abstract][Full Text] [Related]
22. Endocytosis of MHC molecules by B cell-B lymphoma and B cell-T lymphoma hybrids.
Aragnol D; Malissen B; Schiff C; Piron MA; Leserman LD
J Immunol; 1986 Nov; 137(10):3347-53. PubMed ID: 3095429
[TBL] [Abstract][Full Text] [Related]
23. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
24. Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells.
Latron F; Jotterand-Bellomo M; Maffei A; Scarpellino L; Bernard M; Strominger JL; Accolla RS
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2229-33. PubMed ID: 3127829
[TBL] [Abstract][Full Text] [Related]
25. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
[TBL] [Abstract][Full Text] [Related]
26. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.
Lisowska-Grospierre B; Charron DJ; de Préval C; Durandy A; Griscelli C; Mach B
J Clin Invest; 1985 Jul; 76(1):381-5. PubMed ID: 3860509
[TBL] [Abstract][Full Text] [Related]
27. HLA-DR alpha chain expression in human thyroid cells.
Piccinini LA; Schachter BS; Davies TF
Endocrinology; 1986 Jun; 118(6):2611-3. PubMed ID: 3084225
[TBL] [Abstract][Full Text] [Related]
28. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.
Salter RD; Howell DN; Cresswell P
Immunogenetics; 1985; 21(3):235-46. PubMed ID: 3872841
[TBL] [Abstract][Full Text] [Related]
29. aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.
Accolla RS; Jotterand-Bellomo M; Scarpellino L; Maffei A; Carra G; Guardiola J
J Exp Med; 1986 Jul; 164(1):369-74. PubMed ID: 3088202
[TBL] [Abstract][Full Text] [Related]
30. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes.
de Préval C; Lisowska-Grospierre B; Loche M; Griscelli C; Mach B
Nature; 1985 Nov 21-27; 318(6043):291-3. PubMed ID: 3934559
[TBL] [Abstract][Full Text] [Related]
31. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma.
Gonwa TA; Frost JP; Karr RW
J Immunol; 1986 Jul; 137(2):519-24. PubMed ID: 3088102
[TBL] [Abstract][Full Text] [Related]
32. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of HLA-class II antigen mRNAs on T lymphoblasts].
Tate G; Katagiri M
Hokkaido Igaku Zasshi; 1986 Mar; 61(2):249-56. PubMed ID: 3487495
[TBL] [Abstract][Full Text] [Related]
34. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.
Collins T; Korman AJ; Wake CT; Boss JM; Kappes DJ; Fiers W; Ault KA; Gimbrone MA; Strominger JL; Pober JS
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4917-21. PubMed ID: 6431411
[TBL] [Abstract][Full Text] [Related]
35. Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation.
Charron DJ; Lotteau V; Turmel P
Nature; 1984 Nov 8-14; 312(5990):157-9. PubMed ID: 6209579
[TBL] [Abstract][Full Text] [Related]
36. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
37. Antigen-dependent selection of B lymphoma cells varying in Ia density by cloned antigen-specific L3T4a+ T cells: a possible in vitro model for B cell adaptive differentiation.
Tite JP; Janeway CA
J Mol Cell Immunol; 1984; 1(4):253-65. PubMed ID: 6336593
[TBL] [Abstract][Full Text] [Related]
38. Somatic cell hybrids between macrophages from Bcgr and Bcgs mice: characterization of MHC class II expression.
Faris M; Zwilling BS
Cell Immunol; 1990 Apr; 127(1):120-9. PubMed ID: 2180586
[TBL] [Abstract][Full Text] [Related]
39. Low expression of human histocompatibility leukocyte antigen-DR is associated with hypermethylation of human histocompatibility leukocyte antigen-DR alpha gene regions in B cells from patients with systemic lupus erythematosus.
Sano H; Compton LJ; Shiomi N; Steinberg AD; Jackson RA; Sasaki T
J Clin Invest; 1985 Oct; 76(4):1314-22. PubMed ID: 2997276
[TBL] [Abstract][Full Text] [Related]
40. The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells.
Accolla RS; Carra G; Buchegger F; Carrel S; Mach JP
J Immunol; 1985 May; 134(5):3265-71. PubMed ID: 3872331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
